Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule - PubMed (original) (raw)
Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule
Jonathan A Hill et al. J Immunol. 2003.
Abstract
Rheumatoid arthritis (RA) is genetically associated with MHC class II molecules that contain the shared epitope. These MHC molecules may participate in disease pathogenesis by selectively binding arthritogenic peptides for presentation to autoreactive CD4(+) T cells. The nature of the arthritogenic Ag is not known, but recent work has identified posttranslationally modified proteins containing citrulline (deiminated arginine) as specific targets of the IgG Ab response in RA patients. To understand how citrulline might evoke an autoimmune reaction, we have studied T cell responses to citrulline-containing peptides in HLA-DRB1*0401 transgenic (DR4-IE tg) mice. In this study, we demonstrate that the conversion of arginine to citrulline at the peptide side-chain position interacting with the shared epitope significantly increases peptide-MHC affinity and leads to the activation CD4(+) T cells in DR4-IE tg mice. These results reveal how DRB1 alleles with the shared epitope could initiate an autoimmune response to citrullinated self-Ags in RA patients.
Similar articles
- A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis.
Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, Wijeyewickrema LC, Eckle SB, van Heemst J, Pike RN, McCluskey J, Toes RE, La Gruta NL, Purcell AW, Reid HH, Thomas R, Rossjohn J. Scally SW, et al. J Exp Med. 2013 Nov 18;210(12):2569-82. doi: 10.1084/jem.20131241. Epub 2013 Nov 4. J Exp Med. 2013. PMID: 24190431 Free PMC article. - An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A, Elferink DG, Geluk A, van Der Zanden AL, Vos K, Schreuder GM, Breedveld FC, de Vries RR, Zanelli EH. Snijders A, et al. J Immunol. 2001 Apr 15;166(8):4987-93. doi: 10.4049/jimmunol.166.8.4987. J Immunol. 2001. PMID: 11290778 - Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A. Feitsma AL, et al. Arthritis Rheum. 2010 Jan;62(1):117-25. doi: 10.1002/art.25059. Arthritis Rheum. 2010. PMID: 20039411 - Immunity to citrullinated proteins in rheumatoid arthritis.
Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. Klareskog L, et al. Annu Rev Immunol. 2008;26:651-75. doi: 10.1146/annurev.immunol.26.021607.090244. Annu Rev Immunol. 2008. PMID: 18173373 Review. - Genetic background of tolerance breakdown in rheumatoid arthritis.
Kochi Y. Kochi Y. Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(2):48-56. doi: 10.2177/jsci.33.48. Nihon Rinsho Meneki Gakkai Kaishi. 2010. PMID: 20453439 Review.
Cited by
- A Chemical Approach to Assess the Impact of Post-translational Modification on MHC Peptide Binding and Effector Cell Engagement.
Kelly JJ, Bloodworth N, Shao Q, Shabanowitz J, Hunt D, Meiler J, Pires MM. Kelly JJ, et al. ACS Chem Biol. 2024 Sep 20;19(9):1991-2001. doi: 10.1021/acschembio.4c00312. Epub 2024 Aug 16. ACS Chem Biol. 2024. PMID: 39150956 Free PMC article. - Autoantibodies Serum Level and 10-Year Risk of Fractures Evaluated by FRAX® Tool in Rheumatoid Arthritis Patients.
Sghiri R, Ben Hassine H, Ghozzi M, El Amri N, Baccouche K, Sarraj R, Shakoor Z, Almogren A, Bouajina E. Sghiri R, et al. Open Access Rheumatol. 2024 Jul 12;16:137-145. doi: 10.2147/OARRR.S466625. eCollection 2024. Open Access Rheumatol. 2024. PMID: 39045423 Free PMC article. - The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4.
Loh TJ, Lim JJ, Jones CM, Dao HT, Tran MT, Baker DG, La Gruta NL, Reid HH, Rossjohn J. Loh TJ, et al. Nat Commun. 2024 Jul 23;15(1):6201. doi: 10.1038/s41467-024-50511-w. Nat Commun. 2024. PMID: 39043656 Free PMC article. - Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
Pérez-Pérez ME, Nieto-Torres E, Bollain-Y-Goytia JJ, Delgadillo-Ruíz L. Pérez-Pérez ME, et al. Int J Mol Sci. 2024 May 10;25(10):5192. doi: 10.3390/ijms25105192. Int J Mol Sci. 2024. PMID: 38791230 Free PMC article. - The Role of Citrullination Modification in CD4+ T Cells in the Pathogenesis of Immune-Related Diseases.
Chen Y, Teng Y, Xu P, Wang S. Chen Y, et al. Biomolecules. 2024 Mar 26;14(4):400. doi: 10.3390/biom14040400. Biomolecules. 2024. PMID: 38672418 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous